Tirofiban Hydrochloride Monohydrate Market

Tirofiban hydrochloride is A Nonpeptide Glycoprotein IIb/IIIa Receptor Antagonist
Tirofiban HCL is a reversible antagonist of fibrinogen binding to the platelet glycoprotein (GP) IIb/IIIa receptor, the major platelet surface receptor. GP IIb/IIIa plays a major role in the regulation of platelet adhesion and aggregation during hemostasis, and the GP IIb/IIIa receptor has been identified as the pivotal mediator of platelet aggregation. Therefore, tirofiban hydrochloride specifically inhibits fibrinogen-dependent platelet aggregation and prolongs bleeding times
Tirofiban Hydrochloride Monohydrate Market contains market size and forecasts of Tirofiban Hydrochloride Monohydrate in global, including the following market information:
Global Tirofiban Hydrochloride Monohydrate Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Tirofiban Hydrochloride Monohydrate Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Tirofiban Hydrochloride Monohydrate companies in 2021 (%)
The global Tirofiban Hydrochloride Monohydrate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity 97% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Tirofiban Hydrochloride Monohydrate include AbMole BioScience, AK Scientific Inc, BioCrick BioTech, BIOZOL Diagnostics Vertrieb, Combi-Blocks Inc, Glentham Life Sciences Limited, Pharmaffiliates, Watson and Xi'an Wanlong Pharmaceutical. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Tirofiban Hydrochloride Monohydrate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tirofiban Hydrochloride Monohydrate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Tirofiban Hydrochloride Monohydrate Market Segment Percentages, by Type, 2021 (%)
Purity 97%
Purity 98%
Purity 99%
Global Tirofiban Hydrochloride Monohydrate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Tirofiban Hydrochloride Monohydrate Market Segment Percentages, by Application, 2021 (%)
Medicine
Chemical
Other
Global Tirofiban Hydrochloride Monohydrate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Tirofiban Hydrochloride Monohydrate Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tirofiban Hydrochloride Monohydrate revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Tirofiban Hydrochloride Monohydrate revenues share in global market, 2021 (%)
Key companies Tirofiban Hydrochloride Monohydrate sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Tirofiban Hydrochloride Monohydrate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbMole BioScience
AK Scientific Inc
BioCrick BioTech
BIOZOL Diagnostics Vertrieb
Combi-Blocks Inc
Glentham Life Sciences Limited
Pharmaffiliates
Watson
Xi'an Wanlong Pharmaceutical